Search clinical trials for: Olesoxime

Total 7 results

Hoffmann-La Roche
European Commission

Completed

Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS (MITOTARGET)

Amyotrophic Lateral Sclerosis

Belgium, France, Germany, Spain, United Kingdom
Hoffmann-La Roche

Completed

A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA)

Muscular Atrophy, Spinal

Belgium, United Kingdom, Germany, France, Italy, Netherlands, Poland
Hoffmann-La Roche
Hôpital de la Timone; SGS S.A.; STRAGEN Services

Completed

Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta. (MSREPAIR)

Relapsing Remitting Multiple Sclerosis

France
Hoffmann-La Roche

Completed

Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy (CIPN)

Chemotherapy-Induced Peripheral Neuropathy

France
Hoffmann-La Roche
Association Française contre les Myopathies (AFM), Paris

Completed

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non Ambulant

Germany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
Hoffmann-La Roche

Completed

Safety Extension Study of TRO19622 in ALS

Amyotrophic Lateral Sclerosis

Belgium, France, Germany, Spain, United Kingdom
Hoffmann-La Roche
Trophos SA

Completed

A Study of the Excretion Balance of Radiocarbon and the Pharmacokinetics and Metabolic Profile of TRO19622 (Olesoxime)

Healthy Volunteer

Search clinical trials for: Olesoxime

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations